Phase II study of Gleevec® plus hydroxyurea in adults with progressive or recurrent low-grade glioma()

BACKGROUND: We evaluated the efficacy of imatinib plus hydroxyurea in patients with progressive/recurrent low-grade glioma. METHODS: A total of 64 patients with recurrent/progressive low-grade glioma were enrolled in this single-center study that stratified patients into astrocytoma and oligodendrog...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Reardon, David A., Desjardins, Annick, Vredenburgh, James J., Herndon, James E., Coan, April, Gururangan, Sridharan, Peters, Katherine B., McLendon, Roger, Sathornsumetee, Sith, Rich, Jeremy N., Lipp, Eric S., Janney, Dorothea, Friedman, Henry S.
Format: Artigo
Sprog:Inglês
Udgivet: 2012
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3748946/
https://ncbi.nlm.nih.gov/pubmed/22371319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26541
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker